🇺🇸 FDA
Pipeline program

CISPLATIN, CARBOPLATIN

SPON1610-17

Phase 3 small_molecule active

Quick answer

CISPLATIN, CARBOPLATIN for Human papillomavirus (HPV)-positive oropharyngeal cancer is a Phase 3 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
Cardiff Oncology
Indication
Human papillomavirus (HPV)-positive oropharyngeal cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials